Haggai Schermann1, Yuval Heled2, Chen Fleischmann3, Itay Ketko3, Nathan Schiffmann3, Yoram Epstein2, Ran Yanovich3. 1. Institute of Military Physiology, IDF Medical Corps, Israel; Heller Institute of Medical Research, Sheba Medical Center, affiliated with Tel Aviv University, Israel; Division of Orthopedic Surgery, Tel Aviv Sourasky Medical Center, affiliated with Tel Aviv University, Tel Aviv, Israel. Electronic address: sheralmi@bu.edu. 2. Heller Institute of Medical Research, Sheba Medical Center, affiliated with Tel Aviv University, Israel. 3. Institute of Military Physiology, IDF Medical Corps, Israel; Heller Institute of Medical Research, Sheba Medical Center, affiliated with Tel Aviv University, Israel.
Abstract
OBJECTIVES: Heat-tolerance-testing (HTT) protocol is used as a screening test for secondary prevention of exertional heat illness (EHI) in the military. Subjects whose test results are positive (heat-intolerant, HI) are presumed to be at higher risk of repeated EHI events than heat-tolerant subjects (HT) and are therefore prevented from return to combat duty, but may return to unsupervised recreational activity. Our aim was to determine, whether HTT results predict the risk of repeated episodes of exertional heat illness (EHI). DESIGN: Retrospective cohort. METHODS: One-hundred-forty-five subjects (110 HT, 35 HI) who were diagnosed with an EHI event by a physician and underwent HTT during 2008-2015 were contacted and asked about recurrence of EHI. Incidence of recurrent events was reported as number of cases per 1000 person-years. Ratio of events among HI and HT individuals was presented as rate ratio (RR) and its 95% confidence interval. RESULTS: Of the 145 patients, six (4.1%) had experienced recurrent EHI events (10.63 per 1000PY): four HI subjects (11.4%, 26.6 per 1000PY) and two HT (1.8%, 4.8 per 1000PY) (RR=5.504, CI 95%=1.01-30, p=0.027). Only one of the six recurrent events was a heat stroke (HT individual), other five were heat exhaustions. Sensitivity, specificity and diagnostic accuracy of HTT were 66.7%, 77.7% and 77.2%, respectively. CONCLUSIONS: The risk of EHI recurrence is measurable and can be discussed with patients before they return to sports. A referral to HTT can be considered, as negative HTT result is associated with substantial and significant EHI risk reduction.
OBJECTIVES: Heat-tolerance-testing (HTT) protocol is used as a screening test for secondary prevention of exertional heat illness (EHI) in the military. Subjects whose test results are positive (heat-intolerant, HI) are presumed to be at higher risk of repeated EHI events than heat-tolerant subjects (HT) and are therefore prevented from return to combat duty, but may return to unsupervised recreational activity. Our aim was to determine, whether HTT results predict the risk of repeated episodes of exertional heat illness (EHI). DESIGN: Retrospective cohort. METHODS: One-hundred-forty-five subjects (110 HT, 35 HI) who were diagnosed with an EHI event by a physician and underwent HTT during 2008-2015 were contacted and asked about recurrence of EHI. Incidence of recurrent events was reported as number of cases per 1000 person-years. Ratio of events among HI and HT individuals was presented as rate ratio (RR) and its 95% confidence interval. RESULTS: Of the 145 patients, six (4.1%) had experienced recurrent EHI events (10.63 per 1000PY): four HI subjects (11.4%, 26.6 per 1000PY) and two HT (1.8%, 4.8 per 1000PY) (RR=5.504, CI 95%=1.01-30, p=0.027). Only one of the six recurrent events was a heat stroke (HT individual), other five were heat exhaustions. Sensitivity, specificity and diagnostic accuracy of HTT were 66.7%, 77.7% and 77.2%, respectively. CONCLUSIONS: The risk of EHI recurrence is measurable and can be discussed with patients before they return to sports. A referral to HTT can be considered, as negative HTT result is associated with substantial and significant EHI risk reduction.
Authors: Rebecca L Stearns; Yuri Hosokawa; William M Adams; Luke N Belval; Robert A Huggins; John F Jardine; Rachel K Katch; Robert J Davis; Douglas J Casa Journal: Medicina (Kaunas) Date: 2020-12-21 Impact factor: 2.430